BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 11654440)

  • 1. Institutional review board approval required by rule.
    Maloney DM
    Hum Res Rep; 1996 Aug; 11(8):3. PubMed ID: 11654440
    [No Abstract]   [Full Text] [Related]  

  • 2. The FDA's final regulations: IRBs and medical devices.
    Holder AR
    IRB; 1980; 2(6):1-4. PubMed ID: 11661803
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of institutional review boards on clinical research.
    Levine RJ
    Perspect Biol Med; 1980 Pt 2): S99-S114, Winter; 23(2):. PubMed ID: 11663073
    [No Abstract]   [Full Text] [Related]  

  • 4. Informed consent process and document is criticized in court.
    Maloney DM
    Hum Res Rep; 1994 Dec; 9(12):4-5. PubMed ID: 11654162
    [No Abstract]   [Full Text] [Related]  

  • 5. OPRR and FDA propose revised expedited review categories.
    McGough H
    IRB; 1998; 20(1):9, 11. PubMed ID: 11655326
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA revises informed consent regulations for emergency research.
    Menasché A; Levine RJ
    IRB; 1995; 17(5-6):19-22. PubMed ID: 11653359
    [No Abstract]   [Full Text] [Related]  

  • 7. Proposal on waiver of informed consent poses major issues for research ethics.
    Maloney DM
    Hum Res Rep; 1997 Sep; 12(9):1-3. PubMed ID: 11660533
    [No Abstract]   [Full Text] [Related]  

  • 8. Informed consent: the FDA's perspective.
    Bagley G
    Food Drug Law J; 1993; 48(2):181-6. PubMed ID: 11653141
    [No Abstract]   [Full Text] [Related]  

  • 9. IRB review of adverse events in investigational drug studies.
    Prentice ED; Gordon B
    IRB; 1997; 19(6):1-4. PubMed ID: 11656910
    [No Abstract]   [Full Text] [Related]  

  • 10. Federal agency's final rule says informed consent forms must be dated.
    Maloney DM
    Hum Res Rep; 1996 Dec; 11(12):1-2. PubMed ID: 11655034
    [No Abstract]   [Full Text] [Related]  

  • 11. The Food and Drug Administration's role in the protection of human subjects.
    Nightingale SL
    IRB; 1983; 5(1):6-9. PubMed ID: 11649511
    [No Abstract]   [Full Text] [Related]  

  • 12. Commission says institutional review boards should change procedures now.
    Maloney DM
    Hum Res Rep; 1999 Jan; 14(1):1-2. PubMed ID: 11657555
    [No Abstract]   [Full Text] [Related]  

  • 13. Considering experimentation and elusive truth: informed consent made difficult.
    Brodeur D
    Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444
    [No Abstract]   [Full Text] [Related]  

  • 14. Institutional review board becomes enmeshed in lawsuit.
    Maloney DM
    Hum Res Rep; 1994 Nov; 9(11):4. PubMed ID: 11654163
    [No Abstract]   [Full Text] [Related]  

  • 15. Two rules on expedited IRB reviews are final.
    Maloney DM
    Hum Res Rep; 1999 Jan; 14(1):3. PubMed ID: 11657557
    [No Abstract]   [Full Text] [Related]  

  • 16. Court tells jury to ignore human subject protection regulations.
    Maloney DM
    Hum Res Rep; 1995 Mar; 10(3):4-5. PubMed ID: 11654195
    [No Abstract]   [Full Text] [Related]  

  • 17. The noninstitutional review board: a case history.
    Herman SS
    IRB; 1984; 6(1):1-3, 12. PubMed ID: 11649540
    [No Abstract]   [Full Text] [Related]  

  • 18. The FDA's enforcement of IRBs and patient informed consent.
    Kelsey FO
    Food Drug Cosmet Law J; 1989 Jan; 44(1):13-20. PubMed ID: 11651627
    [No Abstract]   [Full Text] [Related]  

  • 19. Fears mount for gene scrutiny as watchdog faces axe.
    Kiernan V
    New Sci; 1996 Jun; 150(2033):10. PubMed ID: 11656540
    [No Abstract]   [Full Text] [Related]  

  • 20. Informed consent process is deemed "legally and ethically invalid" by witness.
    Maloney DM
    Hum Res Rep; 1995 Jan; 10(1):4-5. PubMed ID: 11660008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.